CELGENE CORP /DE/ 4

Accession 0001209191-16-150176

CIK 0000816284operating

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 4:22 PM ET

Size

63.0 KB

Accession

0001209191-16-150176

Insider Transaction Report

Form 4

Period: 2016-11-10

CELGENE CORP /DE/CELG

PEHL MICHAEL F.

See remarks

Transactions

Exercise/Conversion
Common Stock
2016-11-10$36.36/sh+938$34,106→ 2,566 total
Exercise/Conversion
Common Stock
2016-11-10$114.08/sh+781$89,096→ 3,347 total
Exercise/Conversion
Common Stock
2016-11-10$34.70/sh+1,668$57,880→ 5,015 total
Exercise/Conversion
Common Stock
2016-11-10$36.68/sh+1,668$61,182→ 6,683 total
Exercise/Conversion
Common Stock
2016-11-10$49.48/sh+1,668$82,533→ 8,351 total
Exercise/Conversion
Common Stock
2016-11-10$59.24/sh+1,876$111,134→ 10,227 total
Exercise/Conversion
Common Stock
2016-11-10$71.33/sh+1,876$133,815→ 12,103 total
Exercise/Conversion
Common Stock
2016-11-10$78.12/sh+1,876$146,553→ 13,979 total
Exercise/Conversion
Common Stock
2016-11-10$74.30/sh+1,874$139,238→ 15,853 total
Exercise/Conversion
Common Stock
2016-11-10$87.64/sh+1,250$109,550→ 17,103 total
Exercise/Conversion
Common Stock
2016-11-10$103.10/sh+625$64,438→ 17,728 total
Exercise/Conversion
Common Stock
2016-11-10$117.18/sh+1,250$146,475→ 18,978 total
Exercise/Conversion
Common Stock
2016-11-10$118.57/sh+625$74,106→ 19,603 total
Exercise/Conversion
Common Stock
2016-11-10$109.90/sh+781$85,832→ 20,384 total
Exercise/Conversion
Common Stock
2016-11-10$36.47/sh+1,668$60,832→ 22,052 total
Sale
Common Stock
2016-11-10$121.03/sh−20,424$2,471,917→ 1,628 total
Sale
Common Stock
2016-11-10$121.15/sh−1,628$197,232→ 0 total
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−938→ 0 total
Exercise: $36.36Exp: 2022-01-30→ Common Stock (938 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−781→ 2,344 total
Exercise: $114.08Exp: 2025-11-09→ Common Stock (781 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,668→ 0 total
Exercise: $34.70Exp: 2022-07-30→ Common Stock (1,668 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,668→ 0 total
Exercise: $36.68Exp: 2022-10-31→ Common Stock (1,668 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,668→ 1,668 total
Exercise: $49.48Exp: 2023-01-28→ Common Stock (1,668 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,876→ 1,876 total
Exercise: $59.24Exp: 2023-04-29→ Common Stock (1,876 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,876→ 1,876 total
Exercise: $71.33Exp: 2023-07-29→ Common Stock (1,876 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,876→ 1,876 total
Exercise: $78.12Exp: 2023-10-28→ Common Stock (1,876 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,874→ 3,752 total
Exercise: $74.30Exp: 2024-02-03→ Common Stock (1,874 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,250→ 2,500 total
Exercise: $87.64Exp: 2024-07-28→ Common Stock (1,250 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−625→ 1,250 total
Exercise: $103.10Exp: 2024-10-27→ Common Stock (625 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,250→ 3,750 total
Exercise: $117.18Exp: 2024-12-19→ Common Stock (1,250 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−625→ 1,875 total
Exercise: $118.57Exp: 2025-02-02→ Common Stock (625 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−781→ 2,344 total
Exercise: $109.90Exp: 2025-05-04→ Common Stock (781 underlying)
Exercise/Conversion
Stock Option (right to buy)
2016-11-10−1,668→ 0 total
Exercise: $36.47Exp: 2022-04-30→ Common Stock (1,668 underlying)

Footnotes (3)

[F1]The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $120.99 to $121.22, inclusive. The reporting person undertakes to provide to Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
[F2]The option was fully exercisable.
[F3]The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as Amended and Restated on April 15, 2015).

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CELGENE CORP /DE/

CIK 0000816284

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000816284

Filing Metadata

Form type: 4
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 4:22 PM ET
Size: 63.0 KB

View on SEC.gov